News

Authors comment on Kirby et al.'s remedies for placebo response.

United BioSource Corporation (UBC) today announced the acquisition of MetaWorks, Inc., a leading provider of systematic reviews and meta-analyses to inform development, marketing, and regulatory decision-making regarding health care products and services.

Key to improving R&D productivity is the willingness of drug developers to use new discovery tools, such as pharmacogenomics, to accelerate the pace of translating basic research into viable drug candidates, and the aggressive management of clinical trials, through advanced data analysis and outsourcing, to lower cost sites around the world, said Tufts CSDD Director Kenneth I Kaitin.

ArisGlobal, a leading provider of pharmacovigilance software solutions, announces the general availability of SafetyMart, a comprehensive data mining and signal detection application which facilitates in-depth data analysis and proactive benefit/risk assessment of drug safety data.

PRISYM Medica 5 software features RFID capability and ensures compliance with latest FDA regulations

Closing Thoughts on the state of clinical trials in India today.

Tools for Clinical Trials Professionals

Mr. Nils Behrndt, Deputy Head of Unit, Directorate F2 (Pharmaceuticals), DG Enterprise and Industry, European Commission has agreed to join the TOPRA Advisory Council.

Download the most current BPA statement...

Despite accuracy and security concerns, biometrics are gaining in popularity.

Landmark contract signed in Munich.

At Amsterdam Airport delegates representing the local CRO associations from the Netherlands, Germany, Czech Republic, France, Spain, Italy and United Kingdom were represented for the inaugural meeting of the European CRO Federation (EUCROF).

Merck Sharp & Dohme (MSD) has launched a campaign aimed at raising patients' awareness of the potential risks of counterfeit medicines and the danger of buying prescription-only drugs from unregulated websites.

The purpose of the agreement, signed in August 2003, is to jointly evaluate selected proprietary NicOx nitric oxide-donating compounds in an undisclosed therapeutic area.

Tools for Clinical Trials Professionals

Central laboratories are realizing significant cost and time efficiencies by using standardized data.

Novartis to Acquire Outstanding 58 Percent of Chiron Shares for $45.00 Per Share in Cash

The Convergence of Data: Healthcare and Life Sciences

The Convergence of Data: Healthcare and Life Sciences

The New England Journal of Medicine published the results from a National Institute of Mental Health-funded study titled Clinical Antipsychotic Trial of Intervention Effectiveness – Schizophrenia (CATIE–SZ). ICTI is proud to reveal that the data for this study, conducted with 1493 subjects from 57 clinical sites in 24 states, was collected using an early version of ICTI’s iTrial EDC software.

The pace of industry consolidation shows no signs of slowing down, and more mergers seem inevitable. Who will be the biggest players in another 10 years? Which companies look set to be swallowed up? A leading pharmaceutical analyst and former investment banker made his predictions at the Networking Dinner of the ACT European Summit.

Medidata Chief Medical Officer Ed Ikeguchi to Discuss Future of Clinical Trial Technology and Deliver Hands-On EDC Training with Medidata’s Rave 5.4 platform

A pictorial walk through the Applied Clinical Trials European Summit

Andy Richardson, Zenetar Ltd; Case Study: Use of EDC at Boehringer Ingelheim, Stephane Collet, Boeringer Ingelheim, Andrew Cooper, Oracle Corp.;

News broke last week about the initial success of Merck & Co's experimental vaccine to prevent cervical cancer. Gardasil, a genetically engineered vaccine, blocks infection with two types of human papilloma virus, HPV 16 and 18. This development added to the mood of excitement and air of eager anticipation surrounding the 75-minute workshop given by a leading European expert in vaccine trials.

eResearchTechnology, Inc. (eRT) (Nasdaq: ERES - News), a leading provider of centralized electrocardiographic (ECG) services and e-research technology and services, announced today that it has signed approximately $32 million in third quarter contracts setting a new record for quarterly signings, capped by two late phase program awards from two Top 15 global pharmaceuticals awarded at month end.

All is not well in the world of drug safety, it seems. Speakers and delegates expressed serious concerns about the European Union's new pharmacovigilance system. It is creating a huge bureaucratic burden for ethics committees and investigators, important differences exist between each country's interpretation and implementation of the regulations, and uncertainty surrounds the precise responsibilities of each partner in the clinical trial process.

Welcome to the 12th Annual Applied Clinical Trials European Summit E-Show Daily presented by ACT magazine. This special show daily is designed to give you a recap and highlights of the seminar proceedings and plenary sessions from the conference floor. The conference covered the regulatory climate in Europe and electronic data capture.